5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To describe the long term risk of cervical cancer in women with untreated (that is, undergoing active surveillance) or immediately treated cervical intraepithelial neoplasia grade 2 (CIN2).

          Design

          Nationwide population based historical cohort study.

          Setting

          Danish healthcare registries.

          Participants

          Women with CIN2 diagnosed in 1998-2020 and aged 18-40 years at diagnosis, who had either active surveillance or immediate treatment with large loop excision of the transformation zone (LLETZ). Women with a previous record of CIN2 or worse or LLETZ were excluded.

          Main outcome measure

          A Weibull survival model for interval censored time-to-event data was used to estimate the cumulative risk of cervical cancer. Inverse probability treatment weighting was used to adjust estimates for age, index cytology, calendar year, and region of residence.

          Results

          The cohort included 27 524 women with CIN2, of whom 12 483 (45%) had active surveillance and 15 041 (55%) had immediate LLETZ. During follow-up, 104 cases of cervical cancer were identified—56 (54%) in the active surveillance group and 48 (46%) in the LLETZ group. The cumulative risk of cervical cancer was comparable across the two groups during the active surveillance period of two years. Thereafter, the risk increased in the active surveillance group, reaching 2.65% (95% confidence interval 2.07% to 3.23%) after 20 years, whereas it remained stable in the LLETZ group at 0.76% (0.58% to 0.95%).

          Conclusions

          Undergoing active surveillance for CIN2, thereby leaving the lesion untreated, was associated with increased long term risk of cervical cancer compared with immediate LLETZ. These findings show the importance of continued follow-up of women having active surveillance.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          The Danish Civil Registration System.

          The Danish Civil Registration System (CRS) was established in 1968, and all persons alive and living in Denmark were registered for administrative use. CRS includes individual information on the unique personal identification number, name, gender, date of birth, place of birth, citizenship, identity of parents and continuously updated information on vital status, place of residence and spouses. Since 1968, CRS has recorded current and historical information on all persons living in Denmark. Among persons born in Denmark in 1960 or later it contains complete information on maternal identity. For women born in Denmark in April 1935 or later it contains complete information on all their children. CRS contains complete information on immigrations and emigrations from 1969 onwards, permanent residence in a Danish municipality from 1971 onwards, and full address in Denmark from 1977 onwards. CRS in connection with other registers and biobanks will continue to provide the basis for significant knowledge relevant to the aetiological understanding and possible prevention of human diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Danish Cancer Registry.

            The Danish Cancer Registry was founded in 1942. The Cancer Registry contains data on the incidence of cancer in the Danish population since 1943. Validity of the Cancer Registry is secured by the application of manual quality control routines in the daily production of the Cancer Registry, the application of the automated cancer logic, and the use of multiple notifications from different data sources, which also secures a high degree of completeness. In 2008 the Cancer Registry finished a process of modernisation where reporting became electronic through integration with the patient administrative systems and manual coding was partly replaced by an automatic coding logic.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Danish Pathology Register.

              The National Board of Health, Denmark in 1997 published guidelines for reporting of pathology data and the Danish Pathology Register (DPR) was established. DPR contains patient, pathology, and workload data. All records are subject to error tracing. The DPR covers all pathology data in Denmark. The data is used by the pathologists in the daily diagnostic process. The National Board of Health uses the data in the Danish Cancer Registry and DPR is unique for research as data can be linked to tissue biobanks and clinical databases.
                Bookmark

                Author and article information

                Contributors
                Role: doctoral student
                Role: biostatistician
                Role: professor
                Role: doctoral student
                Role: biostatistician
                Role: deputy director
                Role: consultant
                Journal
                BMJ
                BMJ
                BMJ-UK
                bmj
                The BMJ
                BMJ Publishing Group Ltd.
                0959-8138
                1756-1833
                2023
                29 November 2023
                : 383
                : e075925
                Affiliations
                [1 ]Department of Obstetrics and Gynaecology, Gødstrup Hospital, Herning, Denmark
                [2 ]Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
                [3 ]Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
                [4 ]Department of Obstetrics and Gynaecology, Odense University Hospital, Odense, Denmark
                [5 ]Department of Clinical Research, University of Southern Denmark, Odense, Denmark
                [6 ]Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
                [7 ]Centre for Global Health, National Cancer Institute, Rockville, MD, USA
                Author notes
                Correspondence to: K D Lycke katlyc@ 123456clin.au.dk
                Author information
                https://orcid.org/0000-0003-1657-8600
                Article
                bmj-2023-075925.R2 lyck075925
                10.1136/bmj-2023-075925
                10685285
                38030154
                fed8d589-9273-4263-b077-549ba3c5a9d6
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 24 October 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100009906, Grosserer A.V. Lykfeldt og Hustrus Legat;
                Funded by: FundRef http://dx.doi.org/10.13039/501100010078, Region Midtjylland;
                Funded by: FundRef http://dx.doi.org/10.13039/501100010347, Fabrikant Einar Willumsens Mindelegat;
                Categories
                Research

                Medicine
                Medicine

                Comments

                Comment on this article